The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.55
Bid: 8.50
Ask: 8.60
Change: -0.46 (-5.31%)
Spread: 0.10 (1.176%)
Open: 8.45
High: 8.56
Low: 8.20
Prev. Close: 8.66
ANIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value calculation as at 31 December 2023

9 Feb 2024 07:00

RNS Number : 5652C
Agronomics Limited
09 February 2024
 

9 February 2024

Agronomics Limited

("Agronomics" or the "Company")

Net Asset Value calculation as at 31 December 2023

Agronomics Limited (AIM:ANIC), the leading listed company focused on the field of cellular agriculture, announces that its unaudited Net Asset Valuation ("NAV") per share calculation as at closing on 31 December 2023 was 16.90 pence per share, a 2.5% increase from 16.48 pence per share at 30 September 2023. Net Assets were £168 million, including investments of £146 million and uninvested cash and short-term deposits of £22 million. During the period, no fees were payable or accrued relating to the Shellbay Investments Limited Agreement.

The share price of 9.50 pence at the 31 December 2023 close represented a discount of 44% to the 31 December 2023 NAV per share. The average discount to the prevailing NAV per share over the last 12-month period was 34%. Under IFRS, the Company's unquoted investments are generally carried at cost or the most recent priced funding round.

Jim Mellon, Chair of Agronomics, commented:

Agronomics has a healthy balance sheet entering into 2024 and intends to preserve the majority of its capital for follow-on investments into its existing portfolio companies to assist with the achievement of major milestones such as regulatory approvals, product launches, or building out their commercial facilities. The Company continues to monitor and review new and emerging technologies within the field of cellular agriculture and will also look to expand the portfolio for further diversification should the opportunity arise.

Financing

During the period, 2,210 new ordinary shares were issued following the exercise of warrants. Gross proceeds of £660 were received by the Company.

The Board approved a share buyback programme for an aggregate amount of up to £3m for a period of 6 months commencing on 2nd October 2023. To the period ending 31 December 2023, the Company has yet to initiate any buybacks.

Investment review

During the 3-month period, the Company had two positive revaluations and saw the portfolio companies receive government support and form new strategic partnerships:

· 9 October 2023, portfolio company BlueNalu closed a US$ 33.5 million Series B round led by NEOM with a US$ 20 million investment. The investment was accompanied by the signing of a Memorandum of Understanding with BlueNalu for the commercialisation, marketing and distribution of BlueNalu's cultured seafood.

· 16 November 2023, portfolio company Solar Foods closed an ?8 million Series B financing round through the Finnish-based investment organiser Springvest.

· 1 December 2023, portfolio company Liberation Labs secured a US$ 25 million loan for its biomanufacturing facility in Richmond, Indiana. The loan was awarded by Ameris Bank which received a loan guarantee from the USDA as part of its "Business and Industry" loan guarantee program.

· 5 December 2023, portfolio company Clean Food Group was awarded government funding towards a £1 million project to accelerate novel low-emission food production systems.

 

 

Unaudited to 31 December 2023

£

Current Assets

 

 

 

Investments

145,879,692

 

Uninvested cash and deposits

22,007,344

 

Trade and other receivables

142,258

Current Liabilities

 

 

 

Trade and other creditors

(203,046)

Net Assets

 

167,826,248

Capital and Reserves

 

 

 

Share capital

993

 

Share premium

134,482,024

 

Share reserve

1,686,336

 

Retained earnings

31,656,895

Net assets

 

167,826,248

Shares in Issue

 

993,154,244

Net Asset Value per share

 

16.90 pence

 

The quoted investments within the portfolio are valued under IFRS at bid price.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

ENDS

For further information please contact:

Agronomics Limited

Beaumont Cornish Limited

Canaccord Genuity Limited

Cavendish Securities Plc

Peterhouse Capital Limited

SEC Newgate

The Company

Nomad

Joint Broker

Joint Broker

Joint Broker

Public Relations

Jim Mellon

Denham Eke

Roland Cornish

James Biddle

Andrew Potts

Harry Pardoe

Alex Aylen (Head of Equities)

Giles Balleny

Michael Johnson

Lucy Williams

Charles Goodfellow

Bob Huxford

Anthony Hughes

+44 (0) 1624 639396

info@agronomics.im

+44 (0) 207 628 3396

+44 (0) 207 523 8000

+44 (0) 207 397 8900

+44 (0) 207 469 0936

agronomics@secnewgate.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVUPUQCPUPCPPR
Date   Source Headline
26th Oct 20217:00 amRNSInSilico Medicine sale-Correction of sale proceeds
20th Oct 20218:00 amRNSAgronomics leads investment in California Cultured
12th Oct 20217:00 amRNSExercise of Warrants and Updated TVR
29th Sep 20217:00 amRNSAnnounces Sale of Oritain Shares
28th Sep 20217:00 amRNSNew Age Meats Announces US$ 25 million Series A
22nd Sep 20212:48 pmRNSPortfolio Company Update: Mosa Meat
20th Sep 20217:00 amRNSAgronomics leads VitroLabs Series A Funding
14th Sep 20217:00 amRNSPortfolio Company Update: Meatable
14th Sep 20217:00 amRNSPortfolio Company Update: BlueNalu
13th Sep 20218:00 amRNSSubscription in Formo’s US $50 million Fundraise
30th Jul 20215:34 pmRNSReplacement: Net Asset Valuation to 30 June 2021
30th Jul 202112:02 pmRNSNet Asset Value calculation to 31 June 2021
21st Jul 20211:15 pmRNSPortfolio Company Update: Shiok Meats Pte. Ltd
15th Jul 20217:00 amRNSWarrants to be traded on J P Jenkins
14th Jul 20217:00 amRNSTwo portfolio companies in XPRIZE semi-finals
13th Jul 20217:00 amRNSHalf Year Newsletter
25th Jun 20214:21 pmRNSPortfolio Company LIVEKINDLY Update
24th Jun 20215:03 pmRNSPortfolio Company Formo Update
24th Jun 20217:00 amRNSAnnounces the Sale of InSilico Medicine Inc Shares
28th May 202112:10 pmRNSResults of General Meeting, Issue of Equity & TVR
28th May 20217:00 amRNSAnnounces the Conversion of CellX SAFE
27th May 20217:00 amRNSBroker Option Results
25th May 20217:00 amRNSUpdate regarding Broker Option
20th May 20217:00 amRNSUpdate regarding Broker Option
13th May 20217:00 amRNSAnnounces Secondary Purchase of Shares in Meatable
12th May 20217:00 amRNSResult of Fundraising
11th May 202111:05 amRNSSecond Price Monitoring Extn
11th May 202111:00 amRNSPrice Monitoring Extension
11th May 202110:40 amRNSProposed Fundraise to raise £50 million
6th May 20212:30 pmRNSNew Consultancy Agreement with Shellbay
21st Apr 20218:30 amRNSInvestee Company Update: LegenDairy Foods
21st Apr 20217:00 amRNSNet Asset Value calculation to 31 March 2021
8th Apr 202110:47 amRNSInvestee Company Update: Solar Foods
30th Mar 20217:00 amRNSInvestee Company Update: LIVEKINDLY Fundraise
23rd Mar 20213:00 pmRNSMeatable Announces US$ 47 Million Financing
15th Mar 20212:06 pmRNSSecond Price Monitoring Extn
15th Mar 20212:01 pmRNSPrice Monitoring Extension
15th Mar 202111:05 amRNSSecond Price Monitoring Extn
15th Mar 202111:00 amRNSPrice Monitoring Extension
26th Feb 20217:00 amRNSPortfolio Company Update: LIVEKINDLY Collective
25th Feb 20217:00 amRNSAnnounces Further Investment in VitroLabs
18th Feb 20217:00 amRNSAnnounces Further Investment in Meatable
11th Feb 20217:00 amRNSInvestee Company Update: New Age Meats
3rd Feb 20217:00 amRNSResult of AGM
26th Jan 20217:00 amRNSHalf-year Report
20th Jan 20217:00 amRNSInvestee Company Update: BlueNalu Secures $60m
19th Jan 20213:33 pmRNSExercise of Warrants
18th Jan 20217:00 amRNSNet Asset Value calculation to 31 December 2020
16th Dec 20207:00 amRNSInvestment in SuperMeat
14th Dec 20207:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.